Ana Eia Diagnostic Test Kit
by The Binding Site, Ltd. 510(k)
Active
510(k) K004019
Overview
The Ana Eia Diagnostic Test Kit is an antinuclear antibody immunological test system. It consists of reagents used to measure autoimmune antibodies in serum, body fluids, and tissues that react with cellular nuclear constituents such as ribonucleic acid and deoxyribonucleic acid using immunochemical techniques.
This device is identified by FDA 510(k) number K004019. It is classified under regulation number 866.5100 within the immunology medical specialty.
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK004019 | Date15 Feb 2001 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not known
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 22 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- LJM
- Device Class
- Class II
- Regulation
- 21 CFR Part 866.5100
- Advisory Committee
- Immunology
- FDA Decision
- SESE Substantially Equivalent
Other devices from The Binding Site, Ltd.
Questions
What is the primary purpose of the ANA EIA Diagnostic Test Kit?
This test kit is an antinuclear antibody immunological system designed to measure autoimmune antibodies. It detects antibodies in serum, body fluids, and tissues that react with cellular nuclear constituents, specifically ribonucleic acid and deoxyribonucleic acid.
What technology does this test kit use?
The kit utilizes immunochemical techniques to identify and measure the presence of specific autoimmune antibodies. It is categorized as an enzyme-labeled antinuclear antibody test system.
Is this device recognized by the FDA?
Yes, this device is identified by FDA 510(k) number K004019. It is classified under regulation number 866.5100 within the immunology medical specialty.